Newsletter Subject

💡BSGM off to a great start with a 10 percent gain 📈

From

jasonbondpicks.com

Email Address

jason@b.jasonbondpicks.com

Sent On

Tue, Apr 18, 2023 01:25 PM

Email Preheader Text

I am still really optimistic about this idea. I can’t wait to see how things go today…

I am still really optimistic about this idea. I can’t wait to see how things go today…                                                                                                                                                                                                                                                                                                                                                                                                                 [header] *Sponsored by Lifewater Media. Please see disclosures below. Hey there, it is Jeff Bishop… again! I was thrilled to see that BioSig Technologies (Nasdaq: BSGM) had such a great start for everyone who saw it yesterday when I first introduced it to you. The stock traded around $1.04 nearly all day long, it was pretty boring actually until the end of the day when it finally started to climb higher. BSGM ended the day up over 10%, and that is worth checking a simple email in the morning, if you ask me. 🤷 [BSGM stats] It doesn’t really matter if you “like” to trade when there is an opportunity to find something that can make a 10% move in a day, I think it makes sense to pay attention to it, don’t you? Now, the fact that BSGM started to move so late yesterday makes me optimistic that we could be in the very early innings with this idea. There are no guarantees in life or trading, of course, but recall some of the recent ideas I’ve shared with you that started off very similar to this and then went on to make moves of 17%, 36%, 40% or more in the following days. Yesterday, I noticed that [Yahoo Finance]( upgraded their technical indicator events to reflect the very bullish momentum we’re seeing with BSGM right now. Yet another really strong signal… [BSGM events] I also noticed that [Tickeron](, has some great stats to look at for BSGM. These are the results of previous trading patterns we have seen for this stock in the past. The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where BSGM's RSI Indicator exited the oversold zone, 32 of 38 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend 84%. The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 57 of 67 cases where BSGM's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend 85%. Following a +15.53% 3-day Advance, the price is estimated to grow further. Considering data from situations where BSGM advanced for three days, in 236 of 274 cases, the price rose further within the following month. The odds of a continued upward trend 86%. We all know that you can’t 100% predict the future based on past trading, but these are very solid predictions based on the exact same type of trading setups we are seeing right now. I don’t rely on one single indicator as a trader. Rather I look at a blend of lots of different charts, analysis, and indicators and then come to a conclusion that makes the most sense for me as a trader. If you missed the email I sent out yesterday, I copied the highlights of it below so you can get up-to-speed with BioSig Technologies’ (Nasdaq: BSGM) before the trading session gets underway today. One of the great things about medical devices is that the FDA clearance hurdle is much lower than it is for drug makers. Case in point, BioSig Technologies’ (Nasdaq: BSGM) first product, the PURE EP™ System, is an FDA 510(k) cleared non-invasive class II device, that provides superior, real-time signal visualization allowing physicians to perform insight-based, highly targeted cardiac ablation procedures with increased procedural efficiency and efficacy. (1) This means it has already passed the tests and is ready to go! In fact, to date, physicians have [completed approximately 3000 patient cases]( with the BioSig Technologies’ (Nasdaq: BSGM) System. But first, let’s focus on the price action this year so far. Just look at this chart where I have highlighted the direction changes that were signaled by my custom indicators… Nothing in trading is completely “predictable,” but notice how every time this year the stock has made a major move higher after the indicators crossed over and the stock traded above them? Well, right now, we are on the verge of another crossover event. The stock has entered a consolidation phase and is now starting to wake up. If you look at previous events, those upward moves have been absolutely explosive. 💥 To put it in perspective, just look at how BioSig Technologies (Nasdaq: BSGM) has performed this year vs the SPY. $1000 invested in BSGM at the start of the year would now be over $2500. 💰 $1000 invested in SPY at the same time would be $1080. This is why it is so important to pay attention to the right stocks and make sure you follow them closely. Small stocks like this just have incredible potential right now, if the catalyst is right. Even SeekingAlpha seems to agree with me. Look at this perfect “A rating” they show right now for BioSig Technologies (Nasdaq: BSGM) when it comes to momentum (2)… That is probably why all analysts covering the stock have it rated “BUY” or “STRONG BUY” right now. And get this… the [average analyst rating]( puts a price target for BioSig Technologies (Nasdaq: BSGM) over 300% higher than where it is today (3). When a stock is only trading for “pocket change,” like BSGM, it certainly doesn’t take a lot for it to reach those kinds of price targets. These analysts should know what they are talking about. It is their job, after all. I hope they are right! I can see why analysts are starting to wake up to the story with BioSig Technologies (Nasdaq: BSGM) as well. Their main [product has a massive market opportunity](, it has cleared FDA approval, and now sales are starting to ramp up! (4) I love the price chart right now and the trading action lately. It is awesome to see analysts onboard with this, too. The technicals look pristine to me. But, I have to say one of the things I like most here is the fact that we have seen such [strong insider buying]( (5). Every executive will talk a good game about their own stock when they get in front of the public. But how many small company execs do you see actually put their money where their mouth is and buy their own stock? Well, you can see the BioSig Technologies (Nasdaq: BSGM) team has been very active in the market for their own stock lately… I have to say, I was kind of shocked to see this. Usually, when I pull up insider transactions, it is a flood of selling, not buying – and for good reason! Maybe the BSGM guys know something here?? I am running out of room in this email, there are so many strong points I wanted to bring up! But before I wrap this up, I wanted to get into a little more detail about what the company actually does. BioSig Technologies (Nasdaq: BSGM) is an advanced digital signal processing technology company bringing never-before-seen insights to the treatment of cardiovascular arrhythmias. Their PURE EP™ Platform applies a unique combination of hardware and software to accurately capture intracardiac signals with unprecedented clarity and precision. By viewing pure signals that are absent of saturation, interference, or noise from other medical equipment, physicians can respond to even the most complex cardiac arrhythmias with insight-based, highly targeted cardiac ablation procedures. (PURE EP claims to capture critical cardiac signals — even the most complex — to enhance clinical decision-making) BioSig Technologies (Nasdaq: BSGM) operates within the rapidly growing electrophysiology (EP) marketplace – a [market projected to reach $16B]( by 2028 with a 11.2% growth rate (6). They have a signed [Master Research Agreement]( and announced a Multi-System Evaluation Agreement with Cleveland Clinic, … and a signed Purchase Agreement with San Antonio Methodist Hospital. … and a signed Purchase Agreement with Kansas City Rhythm … and a Master Agreement with Hospital Corporation of America ($75 BILLION market cap industry leader) On top of all of that, BSGM even has 50 allowed & issued design and utility patents. There is a LOT going on here! While I like BSGM a lot for all of the reasons I mentioned above, I really think you should spend some time doing your own research and learn more about the risks and potential rewards. A great place to start is by visiting their [website](. Good luck, and happy trading! To Your Success, *Please see disclosures below *PAID ADVERTISEMENT. RagingBull has been paid fourteen thousand dollars by ach bank transfer by Lifewater Media for advertising BioSig Technologies from a period beginning on April 17 , 2023 through April 18 of the same year. As a result of this advertisement and other marketing efforts, Raging Bull may receive advertising revenue from new advertisers and collect email addresses from readers that it may be able to monetize. As of the date of this advertisement, the owners of Raging Bull, do not hold a position in BioSig Technologies. This advertisement and other marketing efforts may increase investor and market awareness, which may result in an increased number of shareholders owning and trading the securities of BioSig Technologies, increased trading volume, and possibly an increased share price of the BioSig Technologies securities, which may or may not be temporary and decrease once the marketing arrangement has ended. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. This advertisement is for educational and informational purposes only. All material information contained in this advertisement is based on information generally available to the public, which public information is believed to be reliable and accurate. Nevertheless, Raging Bull can guarantee the accuracy or completeness of the information. This advertisement does not purport to be a complete analysis of any company’s financial position. This advertisement or any statements made in it is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular individual. The statements made in this advertisement should NOT be relied upon for purposes of investing in the companies mentioned in this advertisement, nor should they be construed as a personalized recommendation to you to buy, sell, or hold any position in any security mentioned in this advertisement or in any other security or strategy. It is strongly recommended that you consult a licensed or registered professional before making any investment decision. SUBSTANTIAL RISK INVOLVED. Any individual who chooses to invest in any securities of the companies mentioned in this advertisement should do so with caution. Investing or transacting in any securities involves substantial risk; you may lose some, all, or possibly more than your original investment. Readers of this advertisement bear responsibility for their own investment research and decisions, and should use information from this advertisement only as a starting point for doing additional independent research in order to allow individuals to form their own opinion regarding investments. It is easy to lose money investing or trading, and we recommend always seeking individual advice from a licensed or registered professional and educating yourself as much as possible before considering any investments. Our reports/releases are a commercial advertisement and are for general information purposes ONLY. A portion of our business is engaged in the marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our services, joining our site or our email/blog list as well as any social networking platforms we may use. A portion of RagingBull’s business model is to receive financial compensation to promote public companies. To conduct investor relations advertising, marketing and publicly disseminate information not limited to our websites, email, SMS, push notifications. This compensation is a major conflict of interest in our ability to provide unbiased reporting. Therefore, this communication should be viewed as a commercial advertisement only. Note, we periodically conduct interviews and issue stock alerts that we are not compensated for. These are purely for the purpose of company awareness, and to generate subscription revenues. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Frequently, companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the corporate awareness program ceases. Our emails may contain forward-looking statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our website / media webpage. The information in our website / media webpage is believed to be accurate and correct but has not been independently verified and is not guaranteed to be correct. NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Raging Bull, or any of their owners, employees or independent contractors is currently registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. USE OF FORWARD-LOOKING STATEMENTS. Certain statements made in this advertisement may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and 21E of the Exchange Act of 1934. Forward-looking statements often include words such as “believes,” “anticipates,” “estimates,” “expects,” “projects,” “intends,” or other similar expressions of future performance or conduct. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made and are not statements of historical fact. They involve many risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. There is no guarantee that past performance will be indicative of future results. Raging Bull does not undertake an obligation to update forward-looking statements in light of new information or future events. Readers can and should review all public SEC filings made by the companies profiled in the Advertisements at https:// www.sec .gov/ edgar/searchedgar /companysearch TRADEMARKS. All trademarks used in this advertisement are the property of their respective trademark holders and no endorsement by such owners of the contents of the advertisement is made or implied. Update your email preferences or unsubscribe [here]( © Jason Bond Picks 62 Calef Hwy. #233 Lee, NH 03861, United States [[beehiiv logo]Powered by beehiiv](

EDM Keywords (259)

yesterday year wrap within went well wanted wake wait volume visiting viewed verge variety usually using unsubscribe undertake uncertainties type treatment transition transacting trading trader trade top time tickeron thrilled think things tests temporary talking talk take strategy story stock statements starting started start spy spend speed soon software situations site similar signaled shocked shared sent sense selling seen seeing see security securities say saw sales running room risks right review reversal results result respond research rely reliable reflect receive recall reasons ready readers read reach rating ramp ragingbull put purposes purpose purport purely pull public property projections probably price precision potential possibly possible position portion perspective performed perfect past parties owners order optimistic opportunity odds obligation noticed notice note noise near much move mouth morning money monetize missed mentioned means meaning may marketing market making makes make made love lots lot lose look little limited like light life licensed learn know kinds kind job investments investing investigated invest interest information individual indicators indicative increase important idea hope hold highlights highlighted hey hardware guarantees guaranteed guarantee grow go get front form follow focus flood far factors fact exact everyone events even estimated entered engaged endorsement ended end email educational educating easy disclaimer detail decrease decisions day date course could correct copied contents consult construed considering conclusion complex completeness compensation compensated company communication comes come chooses chart certainly catalyst cases buying buy business bsgm bring blend believed beehiiv based background awesome ask appropriate announced analysts agree afford advertisements advertisement active accurate accuracy absent able ability 236 21e 2028 1933 1080 10

Marketing emails from jasonbondpicks.com

View More
Sent On

08/12/2024

Sent On

07/12/2024

Sent On

04/12/2024

Sent On

03/12/2024

Sent On

01/12/2024

Sent On

30/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.